Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Gilead Sciences Inc (GILD)  
$111.75 0.24 (0.22%) as of 4:30 Thu 7/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 1,250,000,000
Market Cap: 139.69(B)
Last Volume: 4,039,811 Avg Vol: 8,501,505
52 Week Range: $66.69 - $117.41
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 500     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  425
Guru Rank Value     : 4.8
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 58,500 363,785 890,125 929,098
Total Sell Value $6,340,726 $37,120,328 $85,050,486 $88,125,595
Total People Sold 3 3 5 5
Total Sell Transactions 7 13 24 33
End Date 2025-04-06 2025-01-03 2024-07-05 2023-07-06

   
Records found: 180
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2025-02-04 4 A $0.00 $0 D/D 12,371 34,011     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-04 4 D $97.99 $4,227,093 D/D (43,138) 171,223     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-02-04 4 A $0.00 $0 D/D 84,488 214,361     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-02-04 4 D $97.99 $10,598,206 D/D (108,156) 617,876     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2025-02-04 4 A $0.00 $0 D/D 224,504 726,032     -
   Patterson Sandra SVP, Controllership   •       •      –    2025-02-04 4 A $0.00 $0 D/D 709 37,787     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2025-02-04 4 D $97.99 $4,474,811 D/D (45,666) 119,979     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2025-02-04 4 A $0.00 $0 D/D 90,505 165,645     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-01-31 4 AS $97.22 $13,822,740 D/D (142,180) 129,873 12%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-01-31 4 OE $57.92 $9,600,576 D/D 142,180 273,053     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2025-01-25 4 D $93.07 $17,404 D/D (187) 21,640     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2025-01-25 4 OE $0.00 $0 D/D 515 21,827     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2025-01-15 4 AS $91.35 $228,375 D/D (2,500) 129,873 18%     
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-12-16 4 AS $91.96 $781,660 D/D (8,500) 132,373 13%     
   Patterson Sandra SVP, Controllership   •       •      –    2024-12-10 4 D $92.34 $37,675 D/D (408) 37,078     -
   Patterson Sandra SVP, Controllership   •       •      –    2024-12-10 4 OE $0.00 $0 D/D 901 37,486     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-12-10 4 D $92.34 $28,256 D/D (306) 21,312     -
   Telman Deborah H EVP, Corporate Affairs & GC   •       •      –    2024-12-10 4 OE $0.00 $0 D/D 639 21,618     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-12-10 4 D $92.34 $155,685 D/D (1,686) 140,873     -
   Dickinson Andrew D Chief Financial Officer   •       •      –    2024-12-10 4 OE $0.00 $0 D/D 3,640 142,559     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-12-10 4 D $92.34 $439,723 D/D (4,762) 501,528     -
   Oday Daniel Patrick Chairman & CEO   •       •      –    2024-12-10 4 OE $0.00 $0 D/D 10,295 506,290     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-12-10 4 D $92.34 $160,579 D/D (1,739) 75,140     -
   Mercier Johanna Chief Commercial Officer   •       •      –    2024-12-10 4 OE $0.00 $0 D/D 3,752 76,879     -
   Parsey Merdad Chief Medical Officer   •       •      –    2024-12-10 4 D $92.34 $163,534 D/D (1,771) 82,850     -
  180 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us